vimarsana.com

Page 6 - இயக்குனர் ஜநரல் ஆரோக்கியம் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New serosurvey shows 56 13% people in Delhi have antibodies against COVID-19, says Health Minister Satyendar Jain

Source: Highlights Health Minister Satyendar Jain on Tuesday said 56.13% of those covered under latest serological survey in Delhi in January have developed antibodies against COVID. The fifth sero survey the largest in the country so far was conducted from January 15 to January 23, he said. More women have antibodies against COVID-19 than men, the minister said. New Delhi: Delhi Health Minister Satyendar Jain on Tuesday said 56.13 per cent of those covered under the latest serological survey in the city in January have developed antibodies against coronavirus. The minister said Delhi was moving towards herd immunity, but we should not go into it as only experts will be able to give a clear picture .

Hospitals directed full facilitation to masses

Over 5,900 get inoculated in Haryana

Over 5,900 get inoculated in Haryana Updated: Updated: In terms of numbers, Gurugram tops the table, Jhajjar records the least Share Article AAA In terms of numbers, Gurugram tops the table, Jhajjar records the least As many as 5,907 beneficiaries – around 80% of the total target of 7,533 were administered the COVID-19 vaccine by the Haryana Health Department at 77 immunisation sites across the State on Saturday. In terms of absolute numbers, Gurugram topped the table with the maximum 608 being vaccinated and Jhajjar recorded the least number of 112 vaccinations. Jind recorded only 52% vaccination the lowest in the State with only 156 people inoculated against the target of 300.

Coronavirus mutant: Govt focus on enhanced genomic surveillance; taskforce suggests same treatment

Coronavirus mutant: Govt focus on enhanced genomic surveillance; taskforce suggests same treatment Coronavirus mutant: Govt focus on enhanced genomic surveillance; taskforce suggests same treatment The Centre has said the focus is on enhanced genomic surveillance consortium in view of a mutated variant of coronavirus detected in the United Kingdom (UK). advertisement UPDATED: December 27, 2020 10:44 IST The coronavirus vaccines will be equally effective against the new mutant of the virus found in UK (Photo: PTI/representational) The central government said on Saturday that a genomic surveillance consortium has been formed for laboratory and epidemiological surveillance of circulating strains of the SARS-CoV-2 in view of a mutated variant of coronavirus detected in the United Kingdom (UK).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.